These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 27753009)
1. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer. Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer. Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577 [TBL] [Abstract][Full Text] [Related]
3. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features. Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644 [TBL] [Abstract][Full Text] [Related]
4. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma. Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852 [TBL] [Abstract][Full Text] [Related]
5. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features. Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer. Cao Q; Lu K; Dai S; Hu Y; Fan W Int J Clin Exp Pathol; 2014; 7(5):2392-401. PubMed ID: 24966949 [TBL] [Abstract][Full Text] [Related]
7. Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. Kan CW; Hahn MA; Gard GB; Maidens J; Huh JY; Marsh DJ; Howell VM BMC Cancer; 2012 Dec; 12():627. PubMed ID: 23272653 [TBL] [Abstract][Full Text] [Related]
8. circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b/c. Liu S; Yuan L; Li J; Liu Y; Wang H; Ren X Ann Med; 2023 Dec; 55(1):908-919. PubMed ID: 36896567 [TBL] [Abstract][Full Text] [Related]
9. miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations. Teng Y; Su X; Zhang X; Zhang Y; Li C; Niu W; Liu C; Qu K Oncotarget; 2016 Dec; 7(49):81621-81633. PubMed ID: 27835595 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer. Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570 [TBL] [Abstract][Full Text] [Related]
11. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer. Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients. Meng X; Joosse SA; Müller V; Trillsch F; Milde-Langosch K; Mahner S; Geffken M; Pantel K; Schwarzenbach H Br J Cancer; 2015 Nov; 113(9):1358-66. PubMed ID: 26393886 [TBL] [Abstract][Full Text] [Related]
13. Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer. Zuberi M; Khan I; Mir R; Gandhi G; Ray PC; Saxena A PLoS One; 2016; 11(4):e0153902. PubMed ID: 27092777 [TBL] [Abstract][Full Text] [Related]
14. Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer. Xu YZ; Xi QH; Ge WL; Zhang XQ Asian Pac J Cancer Prev; 2013; 14(2):1057-60. PubMed ID: 23621186 [TBL] [Abstract][Full Text] [Related]
15. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. Marchini S; Cavalieri D; Fruscio R; Calura E; Garavaglia D; Fuso Nerini I; Mangioni C; Cattoretti G; Clivio L; Beltrame L; Katsaros D; Scarampi L; Menato G; Perego P; Chiorino G; Buda A; Romualdi C; D'Incalci M Lancet Oncol; 2011 Mar; 12(3):273-85. PubMed ID: 21345725 [TBL] [Abstract][Full Text] [Related]
16. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer. Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713 [TBL] [Abstract][Full Text] [Related]
17. Mir-21 and Mir-125b as theranostic biomarkers for epithelial ovarian cancer in Tunisian women. Habel A; Nassar F; Itani M; Bouaziz H; Hadj-Ahmed M; Msheik Z; Stayoussef M; Nasr R; Yacoubi-Loueslati B Afr Health Sci; 2023 Jun; 23(2):256-264. PubMed ID: 38223583 [TBL] [Abstract][Full Text] [Related]
18. High Expression of MicroRNA-200a/b Indicates Potential Diagnostic and Prognostic Biomarkers in Epithelial Ovarian Cancer. Zhang B; Li Y; Li Y; Zhao H; An R Dis Markers; 2022; 2022():2751696. PubMed ID: 35371343 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer. Gao YC; Wu J Tumour Biol; 2015 Jun; 36(6):4843-50. PubMed ID: 25636451 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway. Chen S; Chen X; Xiu YL; Sun KX; Zhao Y PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]